Harmony Biosciences to be Added to the Nasdaq Biotech Index

PLYMOUTH MEETING, Pa., Dec. 17, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it has been...